According to the ingredient’s supplier Nutratech Inc., the study is the longest and highest-dose trial on bitter orange extract to date.
A new study finding weight-management ingredient Advantra Z bitter orange extract (Citrus arantium) without adverse effects when taken up to a twice daily at a dose of 49 mg will be published in Food and Chemistry Toxicology in May. According to the ingredient’s supplier Nutratech Inc. (West Caldwell, NJ), the study is the longest and highest-dose trial on bitter orange extract to date. (The study was available online in February.)
The study assessed the safety of 49 mg of bitter orange extract given to 75 healthy subjects twice daily for 60 days. Researchers observed no adverse cardiovascular, hepatic, renal, or hemopoietic effects. Additionally, they found no significant changes in systolic or diastolic blood pressure, blood chemistries, or blood cell counts in control or in the p-synephrine groups. (P-synephrine is the dominant amine in bitter orange extract.)
On the historical safety consensus for different p-synephrine doses, Nutratech says:
Guidelines from Health Canada support up to 50 mg of p-synephrine per day-or 40 mg of p-synephrine in combination with up to 320 mg of caffeine (October 2011). Intertek Cantox supported p-synephrine dosages up to 60 mg in 2012. However, after reexamining the scientific data in February 2013, the organization concluded that single p-synephrine dosages of up to 70 mg–100 mg-if taken as divided doses over the course of the day-are “not likely to cause adverse effects.” Prior to 2011, most authorities limited daily intake of p-synephrine to 20 and 30 mg.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.